Betterchem
Health     Drug Information     DMFs     Portal     21CFR     Search     Site Map

 
Click here for the latest news from Generic Drug Companies.

 

This API may also appear in…

 

FDA Approval Activities for this Drug…

Reminyl (galantamine hydrobromide) Tablets & Suspension, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NDA 21-169/S-007 & 21-224/S-005 1/30/03 9/9/03 Reminyl (galantamine hydrobromide) Tablets & Suspension, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NDA 21-169/S-003 & 21-224/S-003 4/19/02 5/2/02 Reminyl (galantamine hydrobromide) Solution, Janssen Research Foundation NDA 21-224 6/22/01 11/6/01 11/6/01 3/5/02 Reminyl (galantamine hydrobromide) Tablets, Janssen Research Foundation NDA 21-169 2/28/01 4/9/01 8/16/01 12/18/01 Reminyl Indications: The treatment of mild to moderate dementia of the Alzheimer's type. | Reminyl (galantamine hydrobromide) Extended Release Capsules, Johnson & Johnson, Approval | Galantamine Hydrobromide Tablets, J & J Pharma, Labeling Revision | Galantamine Hydrobromide Oral Solution, J & J Pharma, Labeling Revision | Galantamine Hydrobromide Extended-Release Capsules, J & J Pharma, Labeling Revision

For the most up-to-date approval information, please locate this API using the drug index.


 

Other APIs… A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z

Find API by Brand Name | Health | DMF Index | 21 CFR | Federal Register | Home Page | Site Map

 

 

 

© 2007 Betterchem Corp.